Jasper Therapeutics- Warrants (24/09/2026) Long Term Debt

Jasper Therapeutics- Warrants (24/09/2026) posts a long-term debt of $0 as of March 2026. That compares with $760K in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Jasper Therapeutics- Warrants (24/09/2026)'s long-term debt was $760K. The latest reading is $0 — a 100.0% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Jasper Therapeutics- Warrants (24/09/2026)'s financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for JSPRW's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Jasper Therapeutics- Warrants (24/09/2026)'s other metric pages and overview cover the third.